アジア太平洋地域の処方デジタル治療薬（PDTx）市場
Market Size in USD Billion
CAGR :
% 
 予測期間 |
2022 –2029 |
 市場規模（基準年） |
USD 96.38 Billion |
 Market Size (Forecast Year) |
USD 545.70 Billion |
 CAGR |
% |
| 主要市場プレーヤー |
>アジア太平洋地域の処方デジタル治療薬（PDTx）市場、メカニズム別（入力メカニズム、出力メカニズム）、カテゴリ別（薬物増強、薬物代替）、治療（外来治療、単剤療法）、ソフトウェア別（呼吸器疾患用ソフトウェア、メンタルヘルス用ソフトウェア、オピオイド使用障害用ソフトウェア、糖尿病用ソフトウェア、その他）、サービス別（行動マイクロサービス、医療マイクロサービス）、アプリアクセシビリティ別（Android、iOS、Windows）、アプリタイプ別（ネイティブアプリ、Webアプリ）、アプリケーション別（物質使用障害（SUD）、オピオイド使用障害（OUD）、注意欠陥・多動性障害（ADHD）、アルツハイマー病、大うつ病性障害（MDD）、不眠症、てんかん、運動障害、多発性硬化症、片頭痛、自閉症スペクトラム障害、腫瘍学、炎症、呼吸器、心血管、疼痛管理、代謝疾患、その他）、患者（小児、成人） - 2029年までの業界動向と予測
市場分析と規模
処方箋デジタル療法は、ソフトウェア実装によって主要な疾患を迅速に治療できる独自の戦略です。いつでもどこでもエビデンスに基づく治療を提供し、患者の進行状況に関するデータを医師にリアルタイムで提供できるように設計されています。処方箋デジタル療法は、物質使用障害 (SUD)、オピオイド使用障害 (OUD)、ADHD、大うつ病性障害 (MDD)、不眠症、多発性硬化症、腫瘍学、片頭痛、てんかん、自閉症スペクトラム障害、心血管疾患など、さまざまな疾患に対して開発されており、現在開発段階にあります。さまざまな満たされていない要件を持つ患者にとって、処方箋デジタル療法は生活の中で最も重要な側面となる可能性があります。
Data Bridge Market Researchは、アジア太平洋地域の処方デジタル治療薬（PDTx）市場は2021年に9,638万米ドルと評価され、2022年から2029年の予測期間中に24.2％のCAGRを記録し、2029年には5億4,570万米ドルに達すると予測しています。市場価値、成長率、市場セグメント、地理的範囲、市場プレーヤー、市場シナリオなどの市場洞察に加えて、Data Bridge Market Researchチームがまとめた市場レポートには、詳細な専門家分析、患者疫学、パイプライン分析、価格分析、規制枠組みも含まれています。
レポートの範囲と市場セグメンテーション
|
レポートメトリック |
詳細 |
|
予測期間 |
2022年から2029年 |
|
基準年 |
2021 |
|
歴史的な年 |
2020 (2014 - 2019 にカスタマイズ可能) |
|
定量単位 |
売上高（百万米ドル）、販売数量（個数）、価格（米ドル） |
|
対象セグメント |
Mechanism (Input Mechanisms, Output Mechanisms), Category (Medication Augmentation, Medication Replacement), Treatment (Outpatient Treatment, Monotherapy), Software (Software for Respiratory Conditions, Software for Mental Health, Software for Opioid Use Disorder, Software for Diabetes, Others), Services (Behavioral Microservices, Medical Microservices), App Accessibility (Android, iOS, Windows), App Type (Native Apps, Web Apps), Application (Substance Use Disorder (SUD), Opioid Use Disorder (OUD), Attention Deficit/Hyperactivity Disorder (ADHD), Alzheimer’s Disease, Major Depressive Disorder (MDD), Insomnia, Epilepsy, Movement Disorder, Multiple Sclerosis, Migraine, Autism Spectrum Disorder, Oncology, Inflammation, Respiratory, Cardiovascular, Pain Management, Metabolic Conditions, Others), Patients (Children, Adults), |
|
Countries Covered |
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC) |
|
Market Players Covered |
ResMed (US), SAMSUNGHEALTHCARE (South Korea), Biofourmis (US), Novartis AG (Switzerland), Medtronic (Ireland), Pear Therapeutics, Inc. (US), Voluntis (France) |
|
Market Opportunities |
|
Market Definition
Prescription digital therapies is a type of software that is used to treat a variety of ailments. Prescription digital medicines were created by combining biology and technology. Artificial intelligence, diverse algorithms, and virtual reality are used to create these therapeutic instruments. Patients might use prescription digital therapeutics software and services to get any form of treatment whenever and wherever they needed it. Prescription digital treatments have gained a lot of popularity since they are tightly regulated by the FDA and other regulatory authorities and can only be used with a proper prescription from a doctor.
Asia-Pacific Prescription Digital Therapeutics (PDTx) Market Dynamics
Drivers
- Rise in the prevalence of chronic diseases
The surging prevalence of chronic diseases is a major factor driving the prescription digital therapeutics (PDTx) market's growth rate during the forecast period of 2022-2029. As per the World Health Organization (WHO), 463 million adults would have diabetes in 2020. According to predictions, there would be roughly 629 million diabetics worldwide by 2045.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of prescription digital therapeutics (PDTx) market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.
Furthermore, rising adoption rate of smartphones and tablets will expand the prescription digital therapeutics (PDTx) market. Additionally, increasing government initiatives for better healthcare services and surging geriatric population will result in the expansion of prescription digital therapeutics (PDTx) market. Along with this, easy accessibility, patient comfort, and the potentiality to influence behavioural change will enhance the market's growth rate.
Opportunities
- Strong pipeline of potential products
A significant pipeline of potential items projected to be released throughout the forecast period will provide beneficial opportunities for the prescription digital therapeutics (PDTx) market growth. Pear-011 (anxiety GAD), Pear-015 (depression MDD), which are used in the treatment of adults with chronic insomnia and depression, and CT-152 (major depressive disorder), CT-155 (schizophrenia), which are used in the treatment of adults with schizophrenia and depression, are illustrations of potential pear therapeutics clinical therapeutics products in phase III. As a result, various late-stage drugs in the pipeline are anticipated to give attractive prospects for the digital therapeutics market to flourish.
The market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the biologics market growth. Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will further provide beneficial opportunities for the growth of prescription digital therapeutics (PDTx) during the forecast period.
Restraints/Challenges
On the other hand, patient data privacy concerns will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies and dearth of skilled professionals will challenge the prescription digital therapeutics (PDTx) market. Additionally, strict government regulations and lack of awareness about digital therapeutics in developing countries will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.
This Asia-Pacific prescription digital therapeutics (PDTx) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific prescription digital therapeutics (PDTx) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Prescription digital therapeutics (PDTx) market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Asia-Pacific Prescription Digital Therapeutics (PDTx) Market
COVID-19 has a positive general influence on the prescription digital therapeutics (PDTx) sector. Due to increased global awareness of the relevance of digital health, the prevalence of mental illness, and the rate of drug usage. Furthermore, because individuals were forced to stay at home during the pandemic, less physical exercise, an unhealthy lifestyle, and mental stress increased the prevalence of chronic diseases. As a result, demand for prescription digital therapeutics (PDTx) devices and software is increasing around the world. The industry is expected to increase further since regulatory clearances for prescription digital therapeutics (PDTx)-based treatments have recently been eased.
In the middle of the COVID-19 outbreak, the US FDA issued provisional advice for Pear Therapeutics' mental health medications. It also implies that regulatory agencies recognize the significance of digital therapeutics goods. In addition, digital health businesses in the United States raised USD 5.4 billion in venture capital in the first half of 2020, a record high in the history of digital health funding, indicating that investors believe these solutions are necessary. Hence, the COVID-19 pandemic is predicted to boost the market for prescription digital therapeutics (PDTx).
Asia-Pacific Prescription Digital Therapeutics (PDTx) Market Scope
The Asia-Pacific prescription digital therapeutics (PDTx) market is segmented on the basis of mechanism, category, treatment, software, services, app accessibility, app type, application and patients. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Mechanism
- Input Mechanisms
- Output Mechanisms
Category
- Medication Augmentation
- Medication Replacement
Treatment
- Outpatient Treatment
- Monotherapy
Software
- Software for Respiratory Conditions
- Software for Mental Health
- Software for Opioid Use Disorder
- Software for Diabetes
- Others
Services
- Behavioral Microservices
- Medical Microservices
App Accessibility
- Android
- iOS
- Windows
App Type
- Native Apps
- Web Apps
Application
- Substance Use Disorder (SUD)
- Opioid Use Disorder (OUD)
- Attention Deficit/Hyperactivity Disorder (ADHD)
- Alzheimer’s Disease
- Major Depressive Disorder (MDD)
- Insomnia
- Epilepsy
- Movement Disorder
- Multiple Sclerosis
- 片頭痛
- 自閉症スペクトラム障害
- 腫瘍学
- 炎症
- 呼吸器
- 心臓血管
- 疼痛管理
- 代謝状態
- その他
患者
- 子供たち
- 大人
アジア太平洋地域の 処方デジタル治療薬（PDTx）市場地域分析/洞察
アジア太平洋地域の処方デジタル治療 (PDTx) 市場が分析され、市場規模の洞察と傾向が、上記の国、メカニズム、カテゴリ、治療、ソフトウェア、サービス、アプリのアクセシビリティ、アプリの種類、アプリケーション、患者別に提供されます。
アジア太平洋地域の処方デジタル治療 (PDTx) 市場レポートで取り上げられている国は、中国、日本、インド、韓国、シンガポール、マレーシア、オーストラリア、タイ、インドネシア、フィリピン、アジア太平洋地域のその他の国々 (APAC) です。
日本は、市場シェアと市場収益の面でアジア太平洋の処方デジタル治療（PDTx）市場を支配しており、予測期間中もその優位性は高まり続けるでしょう。これは、医療費の増加と慢性疾患の罹患率の増加が、この地域の市場の成長率をさらに押し上げるためです。
レポートの国別セクションでは、市場の現在および将来の動向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。下流および上流のバリュー チェーン分析、技術動向、ポーターの 5 つの力の分析、ケース スタディなどのデータ ポイントは、各国の市場シナリオを予測するために使用される指標の一部です。また、国別データの予測分析を提供する際には、アジア太平洋ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面する課題、国内関税と貿易ルートの影響も考慮されます。
競争環境とアジア太平洋地域の 処方箋デジタル治療薬（PDTx）市場シェア分析
アジア太平洋の処方デジタル治療薬 (PDTx) 市場の競争状況は、競合他社ごとに詳細を提供します。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、アジア太平洋でのプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性が含まれます。提供されている上記のデータ ポイントは、アジア太平洋の処方デジタル治療薬 (PDTx) 市場に関連する会社の焦点にのみ関連しています。
アジア太平洋地域の処方デジタル治療（PDTx）市場で活動している主要企業は次のとおりです。
- レスメド（米国）
- サムスンヘルスケア（韓国）
- バイオフォーミス（米国）
- ノバルティスAG（スイス）
- メドトロニック（アイルランド）
- ペア・セラピューティクス社（米国）
- ヴォルンティス（フランス）
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 MECHANISM OF PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INESIGHT
4.1 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: LAWS AND REGULATIONS
4.2 PRINCIPLES FOR THE DEVELOPMENT OF PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) GUIDELINES
4.3 HIPAA COMPLIANCE FOR PRESCRIPTION DIGITAL THERAPEUTICS (PDTX)
5 EPIDERMOLOGY
6 PIPELINE ANALYSIS
6.1 LIST OF PIPELINE PRODUCTS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 PRESENCE OF PRODUCT PIPELINE
7.1.2 INCREASING PREVALANCE OF DISEASES
7.1.3 HIGH DEMAND OF PDTX DUE TO THEIR HIGH COST EFFECTIVENESS
7.1.4 INCREASINGLY DOMINANT ROLE OF MOBILE TECHNOLOGY AND ARTIFICIAL INTELLIGENCE (AI) IN OUR EVERYDAY LIVES
7.1.5 PRESENCE OF REIMBURSEMENT
7.2 RESTRAINTS
7.2.1 UNAFFORDABILITY OF DIGITAL THERAPEUTICS
7.2.2 PRIVACY ISSUES IN PRESCRIPTION DIGITAL HEALTHCARE
7.2.3 RESISTANCE FROM TRADITIONAL HEALTHCARE PROVIDERS
7.3 OPPORTUNITIES
7.3.1 INCREASING FUNDING ACTIVITIES
7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.3.3 EXPLORATION OF EMERGING MARKET
7.3.4 INCREASING HEALTHCARE EXPENDITURE
7.4 CHALLENGES
7.4.1 LACK OF SKILLED RESOURCES
7.4.2 EXISTENCE OF TRADITIONAL MEDICATIONS
7.4.3 LONG APPROVAL PROCEDURE
8 IMPACT OF COVID-19 PANDEMIC ON THE ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET
8.1 PRICE IMPACT
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC DECISIONS FOR MANUFACTURERS
8.5 CONCLUSION
9 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM
9.1 OVERVIEW
9.2 INPUT MECHANISMS
9.2.1 PATIENT DATA COLLECTION
9.2.1.1 Cognition
9.2.1.2 Mood
9.2.1.3 Memory
9.2.1.4 Concentration
9.2.1.5 Familial Recognition
9.2.1.6 Others
9.2.2 DEXTERITY OR STEADINESS MEASUREMENT
9.2.2.1 Range of Motion Tests
9.2.2.2 Stretching
9.2.2.3 Others
9.2.3 AUDIO ANALYSIS
9.2.3.1 Shakiness
9.2.3.2 Voice Quality
9.2.3.3 Others
9.2.3.4 Screen
9.2.3.5 Accelerometer
9.2.3.6 Microphone
9.3 OUTPUT MECHANISMS
9.3.1 PATIENT COMMUNICATION
9.3.1.1 Professional Coaching
9.3.1.2 Peer-to-Peer Support
9.3.1.3 Others
9.3.2 ADHERENCE PROMPTS
9.3.2.1 Sleep
9.3.2.2 Diet
9.3.2.3 Inactivity
9.3.2.4 Others
9.3.3 CONTENT DELIVERY
9.3.3.1 Blogs
9.3.3.2 Tips
9.3.3.3 Videos
9.3.3.4 FAQs
9.3.3.5 Others
9.3.3.6 Chat
9.3.3.7 Notification
10 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY
10.1 OVERVIEW
10.2 MEDICATION AUGMENTATION
10.3 MEDICATION REPLACEMENT
11 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT
11.1 OVERVIEW
11.2 OUTPATIENT TREATMENT
11.2.1 COGNITIVE BEHAVIOR THERAPY (CBT)
11.2.2 CONTINGENCY MANAGEMENT
11.2.3 CRAVING OR TRIGGER ASSESSMENT
11.2.4 FLUENCY TRAINING
11.2.5 TRANSMUCOSAL BUPRENORPHINE
11.2.6 OTHERS
11.3 MONOTHERAPY
11.3.1 COGNITIVE RESTRUCTURING
11.3.2 INSOMNIA-SPECIFIC COGNITIVE BEHAVIORAL THERAPY (CBT)
11.3.3 OTHERS
12 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE
12.1 OVERVIEW
12.2 4.2 SOFTWARE FOR DIABETES
12.3 SOFTWARE FOR MENTAL HEALTH
12.4 SOFTWARE FOR RESPIRATORY CONDITIONS
12.5 SOFTWARE FOR OPIOID USE DISORDER
12.6 OTHERS
13 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES
13.1 OVERVIEW
13.2 BEHAVIORAL MICROSERVICES
13.2.1 PHYSICAL ACTIVITY
13.2.2 TELEMEDICINE
13.2.3 CONTROLLED BREATHING
13.2.4 MINDFULNESS TRAINING
13.2.5 RELAXATION TECHNIQUE
13.2.6 DIET OPTIMIZATION
13.2.7 OTHERS
13.3 MEDICAL MICROSERVICES
13.3.1 MEDICATION MANAGEMENT SYSTEM
13.3.2 PATIENT HEALTH QUESTIONNAIRE
13.3.3 HEALTH RECOVERED ENGINE
13.3.4 FAGERSTRÖM TEST
13.3.5 MORISKY MEDICATION ADHERENCE SCALE
13.3.6 FINANCIAL SAVING ENGINE
13.3.7 OTHERS
14 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY
14.1 OVERVIEW
14.2 ANDROID
14.2.1 SMARTPHONE
14.2.2 TABLET
14.3 OS
14.3.1 SMARTPHONE
14.3.2 TABLET
14.4 WINDOWS
14.4.1 SMARTPHONE
14.4.2 TABLET
15 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE
15.1 OVERVIEW
15.2 NATIVE APPS
15.3 WEB APPS
16 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION
16.1 OVERVIEW
16.2 METABOLIC CONDITIONS
16.3 MAJOR DEPRESSIVE DIORDER (MDD)
16.4 RESPIRATORY
16.5 CARDIOVASCULAR
16.6 SUBSTANCE USE DISORDER (SUD)
16.7 OPIOID USE DISORDERS (OUD)
16.8 INSOMNIA
16.9 PAIN MANAGEMENT
16.1 ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)
16.11 MOVEMENT DISORDER
16.12 INFLAMMATION
16.13 ONCOLOGY
16.14 MIGRAINE
16.15 ALZHEIMER’S DISEASE
16.16 EPILEPSY
16.17 MULTIPLE SCLEROSIS
16.18 AUSTISM SPECTRUM DISORDER
16.19 OTHERS
17 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY PATIENTS
17.1 OVERVIEW
17.2 ADULTS
17.3 CHILDREN
18 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY GEOGRAPHY
18.1 ASIA -PACIFIC
18.1.1 JAPAN
18.1.2 CHINA
18.1.3 AUSTRALIA
18.1.4 SOUTH KOREA
18.1.5 INDIA
18.1.6 SINGAPORE
18.1.7 THAILAND
18.1.8 MALAYSIA
18.1.9 INDONESIA
18.1.10 PHILIPPINES
18.1.11 VIETNAM
18.1.12 REST OF ASIA- PACIFIC
19 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: COMPANY LANDSCAPE
19.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
20 SWOT ANALYSIS
21 COMPANY PROFILE
21.1 OMADA HEALTH, INC.
21.1.1 COMPANY SNAPSHOT
21.1.2 PRODUCT PORTFOLIO
21.1.3 RECENT DEVELOPMENTS
21.2 RESMED
21.2.1 COMPANY SNAPSHOT
21.2.2 REVENUE ANALYSIS
21.2.3 COMPANY SHARE ANALYSIS
21.2.4 PRODUCT PORTFOLIO
21.2.5 RECENT DEVELOPMENTS
21.3 SAMSUNG
21.3.1 COMPANY SNAPSHOT
21.3.2 REVENUE ANALYSIS
21.3.3 COMPANY SHARE ANALYSIS
21.3.4 PRODUCT PORTFOLIO
21.3.5 RECENT DEVELOPMENT
21.4 GAIA AG
21.4.1 COMPANY SNAPSHOT
21.4.2 COMPANY SHARE ANALYSIS
21.4.3 PRODUCT PORTFOLIO
21.4.4 RECENT DEVELOPMENTS
21.5 PEAR THERAPEUTICS, INC.
21.5.1 COMPANY SNAPSHOT
21.5.2 COMPANY SHARE ANALYSIS
21.5.3 PRODUCT PORTFOLIO
21.5.4 RECENT DEVELOPMENTS
21.6 WELLDOC’S BLUESTAR
21.6.1 COMPANY SNAPSHOT
21.6.2 PRODUCT PORTFOLIO
21.6.3 RECENT DEVELOPMENTS
21.7 SOLERA NETWORK
21.7.1 COMPANY SNAPSHOT
21.7.2 PRODUCT PORTFOLIO
21.7.3 RECENT DEVELOPMENTS
21.8 AKILI INTERACTIVE LABS, INC.
21.8.1 COMPANY SNAPSHOT
21.8.2 PRODUCT PORTFOLIO
21.8.3 RECENT DEVELOPMENTS
21.9 BETTER THERAPEUTICS, LLC
21.9.1 COMPANY SNAPSHOT
21.9.2 PIPELINE PRODUCT PORTFOLIO
21.9.3 RECENT DEVELOPMENTS
21.1 BIGHEALTH
21.10.1 COMPANY SNAPSHOT
21.10.2 SOLUTION PORTFOLIO
21.10.3 RECENT DEVELOPMENT
21.11 BIOFOURMIS
21.11.1 COMPANY SNAPSHOT
21.11.2 PRODUCT PORTFOLIO
21.11.3 RECENT DEVELOPMENTS
21.12 CLICK THERAPEUTICS, INC.
21.12.1 COMPANY SNAPSHOT
21.12.2 PRODUCT PORTFOLIO
21.12.3 RECENT DEVELOPMENTS
21.13 HAPPIFY, INC.
21.13.1 COMPANY SNAPSHOT
21.13.2 PRODUCT PORTFOLIO
21.13.3 RECENT DEVELOPMENTS
21.14 LIMBIX HEALTH, INC.
21.14.1 COMPANY SNAPSHOT
21.14.2 PRODUCT PORTFOLIO
21.14.3 RECENT DEVELOPMENTS
21.15 NATURALCYCLES NORDIC AB
21.15.1 COMPANY SNAPSHOT
21.15.2 PRODUCT PORTFOLIO
21.15.3 RECENT DEVELOPMENTS
21.16 NUVOAIR AB
21.16.1 COMPANY SNAPSHOT
21.16.2 PRODUCT PORTFOLIO
21.16.3 RECENT DEVELOPMENTS
21.17 SENSYNE HEALTH PLC
21.17.1 COMPANY SNAPSHOT
21.17.2 REVENUE ANALYSIS
21.17.3 PRODUCT PORTFOLIO
21.17.4 RECENT DEVELOPMENTS
21.18 VOLUNTIS
21.18.1 COMPANY SNAPSHOT
21.18.2 REVENUE ANALYSIS
21.18.3 PRODUCT PORTFOLIO
21.18.4 RECENT DEVELOPMENTS
21.19 XEALTH
21.19.1 COMPANY SNAPSHOT
21.19.2 PRODUCT PORTFOLIO
21.19.3 RECENT DEVELOPMENTS
22 QUESTIONNAIRE
23 RELATED REPORTS
表のリスト
LIST OF TABLES
TABLE 1 REGULATORY FRAMEWORK
TABLE 2 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, PIPELINE ANALYSIS
TABLE 3 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM 2019-2027 (USD MILLION)
TABLE 4 ASIA-PACIFIC INPUT MECHANISMS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 5 ASIA-PACIFIC INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 6 ASIA-PACIFIC PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 7 ASIA-PACIFIC DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 8 ASIA-PACIFIC AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 9 ASIA-PACIFICINPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 10 ASIA-PACIFIC OUTPUT MECHANISMS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 11 ASIA-PACIFIC OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 12 ASIA-PACIFIC PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 13 ASIA-PACIFIC ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 14 ASIA-PACIFIC CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 15 ASIA-PACIFIC OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 16 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY 2019-2027 (USD MILLION)
TABLE 17 ASIA-PACIFIC MEDICATION AUGMENTATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 18 ASIA-PACIFIC MEDICATION REPLACEMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 19 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT 2019-2027 (USD MILLION)
TABLE 20 ASIA-PACIFIC OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 21 ASIA-PACIFIC OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 22 ASIA-PACIFIC MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 23 ASIA-PACIFIC MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 24 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE 2019-2027 (USD MILLION)
TABLE 25 ASIA-PACIFIC SOFTWARE FOR DIABETES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 26 ASIA-PACIFIC SOFTWARE FOR MENTAL HEALTH IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 27 ASIA-PACIFIC SOFTWARE FOR RESPIRATORY CONDITIONS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 28 ASIA-PACIFIC SOFTWARE FOR OPIOID USE DIOSRDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 29 ASIA-PACIFIC OTHERS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 30 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES 2019-2027 (USD MILLION)
TABLE 31 ASIA-PACIFIC BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 32 ASIA-PACIFIC BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 33 ASIA-PACIFIC MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 34 ASIA-PACIFIC MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 35 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY 2019-2027 (USD MILLION)
TABLE 36 ASIA-PACIFIC ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 37 ASIA-PACIFIC ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)
TABLE 38 ASIA-PACIFIC IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 39 ASIA-PACIFIC IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)
TABLE 40 ASIA-PACIFIC WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 41 ASIA-PACIFIC WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)
TABLE 42 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2019-2027 (USD MILLION)
TABLE 43 ASIA-PACIFIC NATIVE APPS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 44 ASIA-PACIFIC WEB APPS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 45 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2019-2027 (USD MILLION)
TABLE 46 ASIA-PACIFIC METABOLIC CONDITIONS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 47 ASIA-PACIFIC MAJOR DEPRESSIVE DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 48 ASIA-PACIFIC RESPIRATORY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 49 ASIA-PACIFIC CARDIOVASCULAR IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 50 ASIA-PACIFIC SUBSTANCE USE DISORDERS (SUD) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 51 ASIA-PACIFIC OPIOID USE DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 52 ASIA-PACIFIC INSOMNIA IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 53 ASIA-PACIFIC PAIN MANAGEMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 54 ASIA-PACIFIC ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 55 ASIA-PACIFIC MOVEMENT DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 56 ASIA-PACIFIC INFLAMMATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 57 ASIA-PACIFIC ONCOLOGY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 58 ASIA-PACIFIC MIGRAINE IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 59 ASIA-PACIFIC ALZHEIMER’S DISEASE IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 60 ASIA-PACIFIC EPILEPSY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 61 ASIA-PACIFIC MULTIPLE SCLEROSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 62 ASIA-PACIFIC AUTISM SPECTRUM DISORDERIN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 63 ASIA-PACIFIC OTHER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 64 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY PATIENTS 2019-2027 (USD MILLION)
TABLE 65 ASIA-PACIFIC ADULTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 66 ASIA-PACIFIC CHILDREN IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 67 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 68 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 69 ASIA- PACIFIC INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 70 ASIA- PACIFIC PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 71 ASIA- PACIFIC DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 72 ASIA- PACIFIC AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 73 ASIA- PACIFIC INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 74 ASIA- PACIFIC OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 75 ASIA- PACIFIC PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 76 ASIA- PACIFIC ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 77 ASIA- PACIFIC CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 78 ASIA- PACIFIC OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 79 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 80 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 81 ASIA- PACIFIC OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 82 ASIA- PACIFIC MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 83 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 84 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 85 ASIA- PACIFIC BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 86 ASIA- PACIFIC MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 87 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 88 ASIA- PACIFIC ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 89 ASIA- PACIFIC IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 90 ASIA- PACIFIC WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 91 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 92 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 93 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 94 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 95 JAPAN INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 96 JAPAN PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 97 JAPAN DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 98 JAPAN AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 99 JAPAN INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 100 JAPAN OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 101 JAPAN PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 102 JAPAN ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 103 JAPAN CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 104 JAPAN OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 105 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 106 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 107 JAPAN OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 108 JAPAN MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 109 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 110 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 111 JAPAN BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 112 JAPAN MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 113 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 114 JAPAN ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 115 JAPAN IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 116 JAPAN WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 117 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 118 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 119 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 120 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 121 CHINA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 122 CHINA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 123 CHINA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 124 CHINA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 125 CHINA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 126 CHINA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 127 CHINA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 128 CHINA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 129 CHINA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 130 CHINA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 131 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 132 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 133 CHINA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 134 CHINA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 135 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 136 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 137 CHINA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 138 CHINA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 139 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 140 CHINA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 141 CHINA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 142 CHINA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 143 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 144 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 145 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 146 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 147 AUSTRALIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 148 AUSTRALIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 149 AUSTRALIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 150 AUSTRALIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 151 AUSTRALIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 152 AUSTRALIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 153 AUSTRALIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 154 AUSTRALIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 155 USTRALIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 156 AUSTRALIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 157 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 158 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 159 AUSTRALIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 160 AUSTRALIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 161 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 162 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 163 AUSTRALIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 164 AUSTRALIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 165 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 166 AUSTRALIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 167 AUSTRALIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 168 AUSTRALIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 169 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 170
TABLE 171 USTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 172 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 173 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 174 SOUTH KOREA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 175 SOUTH KOREA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 176 SOUTH KOREA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 177 SOUTH KOREA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 178 SOUTH KOREA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 179 SOUTH KOREA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 180 SOUTH KOREA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 181 SOUTH KOREA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 182 SOUTH KOREA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 183 SOUTH KOREA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 184 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 185 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 186 SOUTH KOREA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 187 SOUTH KOREA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 188 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 189 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 190 SOUTH KOREA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 191 SOUTH KOREA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 192 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 193 SOUTH KOREA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 194 SOUTH KOREA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 195 SOUTH KOREA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 196 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 197 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 198 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 199 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 200 INDIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 201 INDIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 202 INDIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 203 INDIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 204 INDIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 205 INDIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 206 INDIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 207 INDIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 208 INDIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 209 INDIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 210 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 211 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 212 INDIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 213 INDIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 214 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 215 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 216 INDIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 217 INDIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 218 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 219 INDIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 220 INDIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 221 INDIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 222 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 223 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 224 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 225 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 226 SINGAPORE INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 227 SINGAPORE PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 228 SINGAPORE DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 229 SINGAPORE AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 230 SINGAPORE INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 231 INGAPORE OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 232 SINGAPORE PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 233 SINGAPORE ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 234 SINGAPORE CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 235 SINGAPORE OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 236 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 237 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 238 SINGAPORE OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 239 SINGAPORE MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 240 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 241 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 242 SINGAPORE BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 243 SINGAPORE MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 244 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 245 SINGAPORE ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 246 SINGAPORE IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 247 SINGAPORE WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 248 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 249 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 250 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 251 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 252 THAILAND INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 253 THAILAND PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 254 THAILAND DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 255 THAILAND AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 256 THAILAND INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 257 THAILAND OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 258 THAILAND PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 259 THAILAND ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 260 THAILAND CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 261 THAILAND OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 262 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 263 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 264 THAILAND OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 265 THAILAND MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 266 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 267 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 268 THAILAND BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 269 THAILAND MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 270 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 271 THAILAND ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 272 THAILAND IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 273 THAILAND WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 274 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 275 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 276 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 277 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 278 MALAYSIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 279 MALAYSIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 280 MALAYSIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 281 MALAYSIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 282 MALAYSIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 283 MALAYSIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 284 MALAYSIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 285 MALAYSIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 286 MALAYSIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 287 MALAYSIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 288 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 289 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 290 MALAYSIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 291 MALAYSIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 292 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 293 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 294 MALAYSIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 295 MALAYSIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 296 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 297 MALAYSIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 298 MALAYSIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 299 MALAYSIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 300 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 301 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 302 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 303 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 304 INDONESIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 305 INDONESIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 306 INDONESIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 307 INDONESIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 308 INDONESIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 309 INDONESIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 310 INDONESIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 311 INDONESIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 312 INDONESIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 313 INDONESIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 314 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 315 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 316 INDONESIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 317 INDONESIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 318 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 319 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 320 INDONESIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 321 INDONESIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 322 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 323 INDONESIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 324 INDONESIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 325 INDONESIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 326 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 327 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 328 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 329 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 330 PHILIPPINES INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 331 PHILIPPINES PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 332 PHILIPPINES DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 333 PHILIPPINES AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 334 PHILIPPINES INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 335 HILIPPINES OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 336 PHILIPPINES PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 337 PHILIPPINES ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 338 PHILIPPINES CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 339 PHILIPPINES OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 340 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 341 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 342 PHILIPPINES OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 343 PHILIPPINES MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 344 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 345 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 346 PHILIPPINES BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 347 PHILIPPINES MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 348 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 349 PHILIPPINES ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 350 PHILIPPINES IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 351 PHILIPPINES WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 352 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 353 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 354 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 355 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 356 VIETNAM INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 357 VIETNAM PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 358 VIETNAM DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 359 VIETNAM AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 360 VIETNAM INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 361 VIETNAM OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 362 VIETNAM PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 363 VIETNAM ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 364 VIETNAM CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 365 VIETNAM OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 366 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 367 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 368 VIETNAM OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 369 VIETNAM MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 370 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 371 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 372 VIETNAM BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 373 VIETNAM MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 374 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 375 VIETNAM ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 376 VIETNAM IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 377 VIETNAM WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 378 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 379 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 380 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 381 REST OF ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
図表一覧
LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SEGMENTATION
FIGURE 3 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: MULTIVARIATE MODELLING
FIGURE 7 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SEGMENTATION
FIGURE 12 INCREASINGLY DOMINANT ROLE OF MOBILE TECHNOLOGY AND ARTIFICIAL INTELLIGENCE (AI) IN OUR EVERYDAY LIVES AND HIGH DEMAND OF PDTX DUE TO THEIR HIGH COST EFFECTIVENESS IS DRIVING THE ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
FIGURE 13 INPUT MECHANISMS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET IN 2020 & 2027
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET
FIGURE 15 DEATH CAUSE IN EUROPEAN UNION IN 2016
FIGURE 16 OCCURRENCE OF MIGRAINE AS PER THE AUSTRALIAN AND NEW ZEALAND ASSOCIATION OF NEUROLOGISTS ANNUAL SCIENTIFIC MEETING 2017
FIGURE 17 PROJECTED NUMBER OF PEOPLE WITH CHRONIC CONDITIONS (IN MILLIONS)
FIGURE 18 PERCENTAGE OF INTERNET USERS IN 2016 AND 2019
FIGURE 19 HEALTHCARE EXPENDITURE IN 2016 AND 2019
FIGURE 20 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, 2019
FIGURE 21 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, 2019-2027 (USD MILLION)
FIGURE 22 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, CAGR (2020-2027)
FIGURE 23 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, LIFELINE CURVE
FIGURE 24 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, 2019
FIGURE 25 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, 2019-2027 (USD MILLION)
FIGURE 26 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, CAGR (2020-2027)
FIGURE 27 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, LIFELINE CURVE
FIGURE 28 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, 2019
FIGURE 29 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, 2019-2027 (USD MILLION)
FIGURE 30 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, CAGR (2020-2027)
FIGURE 31 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, LIFELINE CURVE
FIGURE 32 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, 2019
FIGURE 33 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, 2019-2027 (USD MILLION)
FIGURE 34 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, CAGR (2020-2027)
FIGURE 35 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, LIFELINE CURVE
FIGURE 36 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, 2019
FIGURE 37 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, 2019-2027 (USD MILLION)
FIGURE 38 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, CAGR (2020-2027)
FIGURE 39 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, LIFELINE CURVE
FIGURE 40 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, 2019
FIGURE 41 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, 2019-2027 (USD MILLION)
FIGURE 42 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, CAGR (2020-2027)
FIGURE 43 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, LIFELINE CURVE
FIGURE 44 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, 2019
FIGURE 45 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, 2019-2027 (USD MILLION)
FIGURE 46 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, CAGR (2020-2027)
FIGURE 47 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, LIFELINE CURVE
FIGURE 48 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, 2019
FIGURE 49 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, 2019-2027 (USD MILLION)
FIGURE 50 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, CAGR (2020-2027)
FIGURE 51 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 52 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, 2019
FIGURE 53 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, 2019-2027 (USD MILLION)
FIGURE 54 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, CAGR (2020-2027)
FIGURE 55 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, LIFELINE CURVE
FIGURE 56 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SNAPSHOT (2019)
FIGURE 57 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY COUNTRY (2019)
FIGURE 58 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY COUNTRY (2020 & 2027)
FIGURE 59 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY COUNTRY (2019 & 2027)
FIGURE 60 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM (2020-2027)
FIGURE 61 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: COMPANY SHARE 2019 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
